Target intelligence / Profile preview

NAD-dependent protein deacetylase sirtuin-3 (SIRT3)

Target
SIRT3
Molecular classification
Enzyme, Histone deacetylase, Protein deacetylase, Post-translational modifying enzyme, Sirtuin family, Mitochondrial protein
01

Overview

NAD-dependent protein deacetylase sirtuin-3 (SIRT3) is a member of the mammalian sirtuin family of proteins, homologs to yeast Sir2, and functions as a major mitochondrial protein deacetylase[1]. SIRT3 catalyzes NAD+-dependent removal of acetyl groups from lysine residues on mitochondrial proteins, playing critical roles in regulating mitochondrial metabolism, energy production, cell survival, adaptation to stress, aging, and epigenetic control. SIRT3 deacetylates various substrates, including mitochondrial ribosomal protein MRPL10 and ceramide synthases, thus influencing mitochondrial protein synthesis and ceramide metabolism[4][6]. SIRT3 exists in two isoforms, with the shorter form active in mitochondria and the long isoform found in other cellular compartments[5]. Altered SIRT3 activity is implicated in diverse diseases, including aging-linked disorders, cardiovascular disease, neurodegeneration, metabolic syndromes, and cancer, and it is being evaluated as a therapeutic target and biomarker for mitochondrial function[5][4].

Other names
Sirtuin-3SIRT3NAD-dependent deacetylase sirtuin-3Silent mating type information regulation 2 homolog 3 (S. cerevisiae)SIR2 homolog 3
02

Mechanism of action

NAD+-dependent deacetylation of lysine residues on target proteins (removal of acetyl groups using NAD+ as cofactor), regulation of substrate activity (such as ceramide synthases, mitochondrial ribosomal proteins, or histone proteins), possibly mono-ADP-ribosylation[1][6].

03

Biological functions

Mitochondrial protein deacetylationRegulation of mitochondrial metabolismControl of cell survivalLongevity regulationStress resistanceRegulation of mitochondrial protein synthesisCeramide metabolismEpigenetic regulation
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseAging-related diseasesMetabolic syndromeStrokeOther (mitochondrial dysfunction)
05

Safety considerations

Potential for off-target mitochondrial dysfunctiontissue-specific effects (beneficial and detrimental outcomes reported, e.g., SIRT3 activation may worsen mitochondrial damage in stroke[5])variable responses based on cell/tissue typesignificance in aging and cancer
06

Interacting drugs

Known modulators are experimental or preclinical; no FDA-approved drugs specifically target SIRT3. Molecules such as nicotinamide, resveratrol (general sirtuin activator), and some small-molecule sirtuin inhibitors/activators may interact with SIRT3 activity[5].
07

Biomarkers

Elevated or deficient SIRT3 levels/activity (may correlate with mitochondrial acetylation status)MRPL10 acetylation status in mitochondria[4]ceramide synthase activityoverall mitochondrial protein acetylation[5]

Beyond the preview

Go deeper on NAD-dependent protein deacetylase sirtuin-3 (SIRT3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAD-dependent protein deacetylase sirtuin-3 (SIRT3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call